xylazine has been researched along with Hearing Loss in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mülazımoğlu, S | 1 |
| Ocak, E | 1 |
| Kaygusuz, G | 1 |
| Gökcan, MK | 1 |
1 other study available for xylazine and Hearing Loss
| Article | Year |
|---|---|
Retroauricular Approach for Targeted Cochlear Therapy Experiments in Wistar Albino Rats.
Topics: Anesthesia; Anesthetics, Dissociative; Animals; Blister; Cochlea; Hearing Loss; Hypnotics and Sedati | 2017 |